33.42  0 (0%)		04-10 09:46
Open: 33.36 High: 33.58 Volume: 80		Pre. Close: 33.42 Low: 33.36 Market Cap: 17(M)

Short term
Mid term
Targets	6-month :	39.99	1-year :	46.71
Resists	First :	34.24	Second :	39.99
Pivot price	32.59
Supports	First :	32.38	Second :	31.24
MAs	MA(5) :	33.35	MA(20) :	32.53
	MA(100) :	35.34	MA(250) :	31.59
MACD	MACD :	-0.1	Signal :	-0.4
%K %D	K(14,3) :	77.2	D(3) :	77.6
RSI	RSI(14): 52.7
52-week	High :	38.16	Low :	24.21

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ HELX ] has closed below upper band by 23.8%. Bollinger Bands are 23.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	33.61 - 33.85	33.85 - 34.03
Low:	32.91 - 33.17	33.17 - 33.36
Close:	33.09 - 33.48	33.48 - 33.78

The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business.

Sat, 04 Apr 2026
How Franklin Genomic Advancements Etf (HELX) Affects Rotational Strategy Timing - Stock Traders Daily

Tue, 24 Mar 2026
(HELX) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Tue, 18 Nov 2025
Franklin Genomic Advancements ETF (NYSE:HELX) - intelligentinvestor.com.au

Sun, 20 Apr 2025
IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (NYSEARCA:IDNA) - Seeking Alpha

Tue, 06 Oct 2020
Franklin Templeton Gives Matt Moberg Three New Funds To Run - Investor's Business Daily

Wed, 26 Feb 2020
ETF Stocks 2026: Complete List of Exchange Traded Funds - Bullish Bears

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: CBOE
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.